Roche Annual Report 2006 - Finance Report
October 2006 the US Food and Drug Administration (FDA) lifted an import alert barring the ...... 1507. 1284. 1917. 1588. 190. 184. Other segment information ...
http://www.roche.com/fb06e.pdf...
|
COMPUTER-AIDED DRUG DISCOVERY AND DEVELOPMENT (CADDD): in silico ...
Stahl M, Guba W, Kansy M. Integrating molecular design resources within modern drug discovery research: the Roche experience. Drug Discovery Today. ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=22...
|
Roche Annual Report 2005 - Finance Report
The US Food and Drug Administration (FDA) approved Tarceva for the treatment of inoperable or metastatic. pancreatic cancer in November 2005 and Roche filed ...
http://www.roche.com/fb05e01.pdf...
|
80-Week Data From a Phase 2 Study
Plasma HIV-1 RNA levels were measured using the Roche Amplicor HIV Monitor ... Impact of drug resistance mutations on virologic response to salvage therapy. ...
http://www.medscape.com/viewarticle/562499_2...
|
Roche Annual Report 2006 - Finance Report
Tarceva, by the anti-influenza drug Tamiflu, and by Bonviva/Boniva and Lucentis. ...... 1507. 1284. 1917. 1588. 190. 184. Other segment information ...
http://www.roche.com/fb06e01.pdf...
|
Recent Updates in LDL
N Engl J Med 2008;358:1507-8. Brown BG, Taylor AJ. ... Significant (≥$10000); Research Grants: Daiichi-Sankyo, Pfizer, Roche, Research Grants: Abbott, ...
http://www.medscape.com/viewarticle/577349_3...
|
Activities of the Triazole Derivative SCH 56592 (Posaconazole ...
Benznidazole (Rochagan) was a product of Roche. ... C-11, 1997) and/or the differential interaction of the drugs with the cell's detoxifying systems. ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=89...
|
ENHANCE Finally Presented, Published
30 Mar 2008 ... "There is little in ENHANCE that is in the drug's favor, .... Roche, AstraZeneca, Merck, and Schering-Plough and grant support from ...
http://www.medscape.com/viewarticle/572221...
|
I GAAP-standalone
31, 3, Other income, 5628, 1507, 10053, 5097, 6964 .... C.V. ( "Falcon"), a Roche group company for a cash consideration of Rs 23214.64 lakhs (USD 51.43 ...
http://www.drreddys.com/investors/pdf/q3fy06igaap.xls...
|
Drugs in development: bisphosphonates and metalloproteinase inhibitors
These symptoms are also seen with the Roche compound Ro 31–9790, and this led to its ..... 1996;11:1498–1507. [PubMed]; Zimolo Z, Wesolowski G, Rodan GA. ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=15...
|
